Australia’s life sciences industry has called for a stronger focus on clinical trials, commercialisation, and investment attraction in the federal government’s forthcoming National Health and Medical Research Strategy.
Life sciences industry calls for stronger national strategy to support trials and innovation
October 9, 2025 Latest NewsAustralian BiotechBioPharma
Latest Video
New Stories
-
Pharmac announces plan to revise it recently expanded patient advisory function
August 4, 2026 - - Latest News -
Australian company announces agreement with Lilly to trial lung cancer combination
August 4, 2026 - - Latest News -
This complete absence of patient power and agency makes this a health system outlier
August 4, 2026 - - Latest News -
Arrotex Pharmaceuticals appoints experienced industry executive as CMO
August 4, 2026 - - Latest News -
The risk to patients is that new pricing policies could swamp any benefit from the HTA Review
August 4, 2026 - - Latest News -
Potential merger could create a new global oncology powerhouse
August 3, 2026 - - Latest News -
The HTA Review and the 'Abilene paradox' - when everyone argues for reforms that nobody wants
August 3, 2026 - - Latest News

